Background Microbial superantigens might initiate or exacerbate autoimmune responses against particular tissues, organs or systems. This study aimed to examine the prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis (MS).
Introduction
Multiple sclerosis (MS) is an inflammatory autoimmune disease characterized by demyelination of the central nervous system (CNS). 1 The demyelination process is associated with infiltrating T cells specific for major myelin proteins into the CNS. The disease has a peak onset between 20 and 40 years old and affects women approximately twice as often as men. [2] [3] [4] The relapsing-remitting MS (RR-MS) form of disease is the most frequent one, involving about 85% to 90% of all the cases. This form of the1 or viral antigens is one of the important mechanisms that represent an explanation for the activation of autoreactive T cells in MS. 10, 11 However, the superantigens (SAgs), because of their strong T cell mitogenic activity, can initiate or exacerbate autoimmune responses against antigens of the central nervous system. SAgs bind to a wide variety of major histocompatibility complex class II (MHC-II) molecules on antigenpresenting cells and T cell receptors (TCR) on T cells. This binding leads to massive polyclonal activation of as much as 20% of the helper T cell repertoire. However, the conventional peptide antigens bind only 1 in 10 5 -10 6 naive T cells. 12, 13 It has been suggested that S. aureus carriage is associated with various autoimmune diseases including Wegener's granulomatosis, lupus erythematosus and rheumatoid arthritis through SAgs such as staphylococcal enterotoxins (SEs) or toxic shock syndrome toxin-1 (tsst-1).
14-16 About 20-30% of the normal human population are asymptomatic carriers of S. aureus in the anterior nares. 17 More than 20 SAgs have been identified in S. aureus strains. Reports show that at least 80% of the clinical strains of S. aureus harbor a minimum of one SAg. 18 The SAg can be efficiently absorbed from nasal mucosa, either directly or facilitated by other exotoxins, such as cytolysins. 19 Recurrent or chronic systemic exposure to an extremely small amount of SAg in S. aureus carriers can also cause absorption of the SAg. The absorption of the SAg can lead to activation of the autoreactive T and Blymphocytes in genetically predisposed individuals. The activation of such autoreactive cells under appropriate conditions can precipitate an autoimmune disease. [18] [19] [20] This study aims to identify the prevalence of staphylococcal enterotoxin A (sea), seb, sec, sed, and tsst-1 genes of S. aureus in nasal carriage and their association with multiple sclerosis. 
Methods

Study population
Sample processing and bacteriological methods
Samples were collected from anterior nares using sterile cotton swab. The nasal swabs were inoculated onto blood agar and incubated at 37°C overnight and they were examined for growth. S. aureus was identified by standard methods, colony morphology, Gram staining, catalase test, fermentation of mannitol, DNase enzyme production and slide and tube coagulase test.
Antibiotic susceptibility testing
Antibiotic susceptibility testing was performed for each S. aureus isolate by the disc diffusion method against cefoxitin, gentamicin, erythromycin, clindamycin, ciprofloxacin, cotrimoxazole, chloramphenicol, rifampin, doxycycline, quinupristin dalfopristin, linezolid and mupirocin. Vancomycin susceptibility testing was also performed by the microdilution method using the Clinical and Laboratory Standards Institute (CLSI) guidelines (2015).
PCR assay for sea, seb, sec, sed and tsst-1
genes
The DNA was extracted from culture isolates of S. aureus by Bioneer kit (Daejeon, Korea). The primers specific to sea, seb, sec, sed and tsst-1 genes were designed and multiple alignments were carried out. The sequence of primers is listed in Table 1 .
According to the kit instruction (PCR Master Mix Kit, SinaClon, Tehran, Iran), each PCR procedure was performed with 5 μL DNA, 12.5 μL 2x master mix, 20 pmol each of the forward and reverse primers) in 25 μL of final volume. The PCR products were analyzed by 1% agarose gel electrophoresis with KBC staining (0.5 µg/mL) (Kowsar, Tehran, Iran). Table  2 .
No significant association was observed between colonization with antibiotics-resistant S. aureus and MS disease. The prevalence of methicillin resistant S. aureus (MRSA) in the patient group was 22.2% (n=14) while in the control group it was 16.7% (n=5). The antibiotic resistance pattern is shown in Table 3 .
Among the MS patients who tested positive for S. aureus, the least prevalent SAg gene identified was sed (accounting for 6.3% of the patients) while the most prevalent one was seb (accounting for 28.6% of the patients) - Table 4 . In the control group, the least prevalent SAg gene was also sed (accounting for 5.7%) while the most prevalent SAg gene was sea (accounting for 28.6% of the colonized individuals in the control group). The prevalence of sea in the MS patients group and seb in the healthy group was 25.4% and 17.1%, respectively. The findings indicated that there is no significant association between the presence of S. aureus harboring sea, seb, sec, sed and tsst-1 genes with MS disease. 
Discussion
Patients with MS are more likely to have impaired T lymphocyte function. Hence, they may be considered as immune-compromised. The prevalence of S. aureus nasal carriage among immunocompromised patients is high compared to the healthy population. 10 In the present study, the nasal carriage rate of S. aureus in MS patients was 42% whilst in the control group it was 23.3%. Similarly, a study in Turkey reported prevalences of 46.6% and 20% among MS patients and control groups, respectively. 22 The relatively high nasal carriage rate of S. aureus may imply that MS patients are more vulnerable to S. aureus colonization due to reduced immunity. In contrast, a study in Canada reported a lower nasal carriage rate of S. aureus among MS patients (27%) and relatively higher in non-MS group (30%). They showed that MS patients were not more susceptible to S. aureus colonization, but in their study, the control groups were not matched with patients in terms of age and sex. 23 In the current study sex classification revealed that female and male patients were not significantly different in the prevalence of S. aureus colonization. Additionally, the age of patients and disease duration had no significant association with S. aureus colonization in MS patients. No differences were observed for the rate of S. aureus in relapsing and non-relapsing patients.
S. aureus strains show considerable diversity in antibiotic resistance globally. Our study compared the frequency of antibiotic resistance of S. aureus in MS patients and healthy individuals. The S. aureus isolates from the healthy individuals and MS patients indicated almost similar resistance rates to antibiotics. All the isolates were susceptible to quinupristindalfopristin, vancomycin and linezolid. The highest rate of resistance was observed for doxycycline and erythromycin. MRSA is one of the major drug-resistant pathogens in the world and treating MRSA infections is problematic because MRSA strains carry resistance genes to other antimicrobial agents. 24, 25 A report from a systematic review showed that the rates of MRSA in Iran ranged from 20.4% to 90%. 26 The overall resistance rates of S. aureus isolates to methicillin were 19.3% (22.2% in MS patients and 16.7% in the healthy population). Based on the molecular detection of MRSA, Melek et al. reported MRSA in 18.1% of MS patients. 22 Differences in the rate of MRSA carriage could be related to the use of different techniques for identifying methicillin resistance.
Among the MS patients and the control group the most prevalent superantigens were seb and sea, separately. However, there was no statistically significant association between seb gene and MS disease. Another study reported that sea was more prevalent in MS patients versus control group (30% in non-MS individuals, 21.2% in MS stable and 27.2% in MS exacerbation groups). They revealed a significant association between S. aureus harboring sea gene and MS exacerbation. 23 In our study, we were unable to evaluate exacerbation in patients with MS, therefore we cannot draw any conclusions regarding the risk of exacerbation.
Conclusions
The risk of S. aureus nasal carriage in our study was higher in MS disease. S. aureus superantigens have been implicated in some immunological diseases such as lupus erythematosus, Wegener's granulomatosis syndrome and rheumatoid arthritis. [14] [15] [16] However, the findings of previous studies are not enough to support the role of superantigens in the induction or exacerbation of MS disease. Further investigation is needed to understand whether SAg positive S. aureus decolonization among MS patients could reduce MS disease severity.
